Skip to content

PEP-TALK: A study investigating whether having group discussions in addition to physiotherapy improves the amount of physical activity following hip and knee replacement

A behaviour change physiotherapy intervention to increase physical activity following hip and knee replacement: a pragmatic phase III randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN29770908
Enrollment
260
Registered
2018-10-23
Start date
2019-03-27
Completion date
Unknown
Last updated
2023-11-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Physical activity after hip or knee replacement Musculoskeletal Diseases Physical activity after hip and knee replacement

Interventions

Participants will be enrolled onto the trial for 12 months, and will be screened to see if they meet the inclusion criteria for the trial prior to their hip or knee replacement surgery. If they meet t

Sponsors

University of Oxford
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. People following primary (first-time) unilateral total hip replacement (THR) or total knee replacement (TKR) where the indication for surgery is degenerative joint pathology (not trauma). Participants post-THR and TKR will be recruited given that there is no difference in physical activity participation between the two cohorts. Both have similar barriers to physical activity engagement which the intervention could address. 2. People who do not meet physical activity levels to benefit health (using the General Practice Physical Activity Questionnaire (GPPAQ)) 3. Aged 18 years or older 4. Charlson Comorbidity Index (CCI) of one point or above 5. Capacity to provide written informed consent as determined by the approaching researcher at screening through an assessment using the AMTS

Exclusion criteria

Exclusion criteria: 1. Absolute contraindication to exercise such as severe cardiovascular or pulmonary disease (New York Heart Association III-IV) 2. Undergo revision (second-time) joint replacement given that surgery and recovery of this population is more complicated. 3. Living in a care home 4. Enrolled onto another trial investigating interventions on physical activity or exercise adherence or behavioural therapy interventions 5. Cannot read and/or comprehend English 6. Do not have access to a working telephone

Design outcomes

Primary

MeasureTime frame
Physical activity, assessed using the University of California Los Angeles (UCLA) Activity Scale at the baseline and after 6 and 12 months

Secondary

MeasureTime frame
The following will be assessed at the baseline and after 6 and 12 months unless otherwise stated: 1. Lower limb function, assessed using the Lower Extremity Functional Scale (LEFS) 2. Hip and knee-specific disability, assessed using the Oxford Hip Score and Oxford Knee Score respectively 3. Pain, assessed using the Numerical Rating Scale for Pain 4. Self-efficacy, assessed using the Generalized Self-Efficacy Scale (GSE) 5. Fear of movement, assessed using the Tampa Scale for Kinesiophobia (TSK) 6. Psychological distress (anxiety and depression), assessed using the Hospital Anxiety and Depression Scale (HADS) 7. Health-related quality of life, assessed using the EQ-5D-5L 8. Complications and adverse events, assessed using self-reported questionnaire complications and an adverse event questionnaire 9. Self-reported health-resource use questionnaire, assessed after 6 and 12 months

Countries

England, United Kingdom

Contacts

Public ContactScott Parsons
pep-talk@ndorms.ox.ac.uk+44 (0)1865 227224

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 18, 2026